AACP is pleased to offer continuing education credits for select sessions presented during the 2024 Annual Meeting in Boston. Please follow the instructions provided below to claim credit for your participation in the accredited CE activities. Questions regarding CE from the Annual Meeting should be sent to: cpd@aacp.org.

Use of Artificial Intelligence (AI) in Pharmacy Education Institute

CPE Activity Announcement

April 3-5, 2024

Virtual

Target Audience

AACP encourages any faculty member, administrator, or staff person to attend. This Institute would be particularly impactful for faculty and staff involved in curriculum and assessment committees, assistant/associate deans of academic affairs, and CEO Deans.

Agenda

The AACP Research and Graduate Affairs committee, under the leadership of Chair Kathy Giacomini and Vice Chair Vicki Ellingrod, is developing a longitudinal (6-8 month), hybrid grant writing program for 2025, with virtual coursework and anchored by an in-person workshop at the AACP annual meeting in July 2025. The program is intended as an intensive grant writing course for pharmacy faculty preparing to submit their first large research or career development proposal (e.g., an NIH R01 or K08 award).  What sets the program apart from other grant writing programs is the extensive use of recently successful NIH grants, as well as examples and experiences drawn from pharmacy faculty and research. Though the focus is on large NIH or NIH-type grants, information presented in the program can be applied to smaller grants, for example from foundations or other entities.

Participants are expected to enter the program with a research project and target funding source and finish with a substantially complete grant proposal for submission in Fall 2025. Participants should have the support of their department chair or dean to attend, given the expected time and resource commitment for the program, including the registration fee and travel costs to the in-person workshop. AACP is currently gauging interest in the program and would appreciate your feedback on the following questions:

At the virtual Institute, April 3-5, attendees will gain new knowledge, skills and opportunities for application of AI in the pharmacy classroom and pharmacy practice settings.

AACP today announced the recipients of its top awards for 2024, which recognize six individuals, one institution, one organization and one scholarly paper, for their outstanding contributions made to pharmacy education, research, patient outcomes, community service and academic publishing.

The diversity of clinical trial participants does not reflect the population of the United States. AACP is seeking to learn about activities at its member schools related to clinical trial recruitment and diversity of clinical trial participants as part of our project, “Mobilizing a Pharmacy Advances Clinical Trials (PACT) Network and Community-based Organizations to Address Diversity in Clinical Trials,” funded by Genentech and the Genentech Foundation Health Equity and Diversity in STEM Innovation Grant. This project aims to create and train a network of community-based pharmacists and partners to enhance clinical trial participation among underrepresented populations.

This information collection is a continuation of a preliminary scan of activities related to clinical trials and participant diversity to gather insights from select schools as part of a collaborative agreement with researchers from the Texas A&M University Irma Lerma Rangel School of Pharmacy funded by the Food and Drug Administration Office of Minority Health and Health Equity. The results of the preliminary scan are promising, highlighting the active participation of pharmacists in initiatives enhancing diversity in clinical trials.

For the purposes of this scan, an activity is broadly defined as a collaboration, initiative, course, partnership, or program contributing to advancing clinical trial diversity in areas such as advocacy, education, teaching, outreach, practice, research, and/or service. The information collected will be used to create a public resource about pharmacy academia’s activities to enhance diversity in clinical trials. Information submitted will be analyzed by members of the project team, and insights from submitted activities and outcomes will be used to form the basis of a strategic framework for utilizing pharmacist-community partnerships to increase clinical trial diversity.

For more information about this initiative, please refer to this Frequently Asked Questions (FAQ) document. 

AACP Executive Vice President and CEO Lee Vermeule